210 related articles for article (PubMed ID: 26159576)
21. Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors.
Li S; Zhao Y; Wang K; Gao Y; Han J; Cui B; Gong P
Bioorg Med Chem; 2013 Jun; 21(11):2843-55. PubMed ID: 23628470
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anticancer activity of novel quinoline-docetaxel analogues.
Chen M; Chen H; Ma J; Liu X; Zhang S
Bioorg Med Chem Lett; 2014 Jul; 24(13):2867-70. PubMed ID: 24835987
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
Tang Q; Zhao Y; Du X; Chong L; Gong P; Guo C
Eur J Med Chem; 2013 Nov; 69():77-89. PubMed ID: 24012712
[TBL] [Abstract][Full Text] [Related]
24. Tetrazolylmethyl quinolines: Design, docking studies, synthesis, anticancer and antifungal analyses.
Shaikh SKJ; Kamble RR; Somagond SM; Devarajegowda HC; Dixit SR; Joshi SD
Eur J Med Chem; 2017 Mar; 128():258-273. PubMed ID: 28192709
[TBL] [Abstract][Full Text] [Related]
25. Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.
Zeng Q; Kwok Y; Kerwin SM; Mangold G; Hurley LH
J Med Chem; 1998 Oct; 41(22):4273-8. PubMed ID: 9784102
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of furonaphth[1,3]oxazine and furo[1,3]oxazinoquinoline derivatives as precursors for an o-quinonemethide structure and potential antitumor agents.
Benameur L; Bouaziz Z; Nebois P; Bartoli MH; Boitard M; Fillion H
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):605-8. PubMed ID: 8882458
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of 6-cinnamoyl-2H-benzo[b][1,4]oxazin-3(4H)-ones and their effects on A549 lung cancer cell growth.
Zhou XW; Ma HL; Zhang X; Jing SY; Miao JY; Zhao BX
Eur J Med Chem; 2014 May; 79():95-101. PubMed ID: 24727462
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and anti-cancer activity of 1,4-disubstituted imidazo[4,5-c]quinolines.
Thigulla Y; Akula M; Trivedi P; Ghosh B; Jha M; Bhattacharya A
Org Biomol Chem; 2016 Jan; 14(3):876-83. PubMed ID: 26592542
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety.
Tang Q; Zhai X; Tu Y; Wang P; Wang L; Wu C; Wang W; Xie H; Gong P; Zheng P
Bioorg Med Chem Lett; 2016 Apr; 26(7):1794-8. PubMed ID: 26944614
[TBL] [Abstract][Full Text] [Related]
30. Optimization of a binding fragment targeting the "enlarged methionine pocket" leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitors.
Huang W; Zhang Z; Ranade RM; Gillespie JR; Barros-Álvarez X; Creason SA; Shibata S; Verlinde CLMJ; Hol WGJ; Buckner FS; Fan E
Bioorg Med Chem Lett; 2017 Jun; 27(12):2702-2707. PubMed ID: 28465105
[TBL] [Abstract][Full Text] [Related]
31. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure-activity relationships of the 1- and 3-positions.
Kemnitzer W; Kuemmerle J; Jiang S; Zhang HZ; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2008 Dec; 18(23):6259-64. PubMed ID: 18952423
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, crystal structures and anticancer activity of 4-substituted quinolines to target PDK1.
Vennila KN; Sunny D; Madhuri S; Ciattini S; Chelazzi L; Elango KP
Bioorg Chem; 2018 Dec; 81():184-190. PubMed ID: 30138906
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and molecular modelling studies of novel 3-acetamido-4-methyl benzoic acid derivatives as inhibitors of protein tyrosine phosphatase 1B.
Rakse M; Karthikeyan C; Deora GS; Moorthy NS; Rathore V; Rawat AK; Srivastava AK; Trivedi P
Eur J Med Chem; 2013; 70():469-76. PubMed ID: 24185377
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors.
Wang X; Zhang C; Zhang X; Yan J; Wang J; Jiang Q; Zhao L; Zhao D; Cheng M
Eur J Med Chem; 2020 May; 194():112243. PubMed ID: 32229389
[TBL] [Abstract][Full Text] [Related]
35. Non-peptide-based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies.
Jaiswal PK; Sharma V; Kumar S; Mathur M; Swami AK; Yadav DK; Chaudhary S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700349. PubMed ID: 29522645
[TBL] [Abstract][Full Text] [Related]
36. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
Rachakonda V; Alla M; Kotipalli SS; Ummani R
Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
Buduma K; Chinde S; Dommati AK; Sharma P; Shukla A; Srinivas KVNS; Arigari NK; Khan F; Tiwari AK; Grover P; Jonnala KK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1633-1638. PubMed ID: 26873414
[TBL] [Abstract][Full Text] [Related]
38. Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines.
Podeszwa B; Niedbala H; Polanski J; Musiol R; Tabak D; Finster J; Serafin K; Milczarek M; Wietrzyk J; Boryczka S; Mol W; Jampilek J; Dohnal J; Kalinowski DS; Richardson DR
Bioorg Med Chem Lett; 2007 Nov; 17(22):6138-41. PubMed ID: 17904844
[TBL] [Abstract][Full Text] [Related]
39. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
Kemnitzer W; Kuemmerle J; Jiang S; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Jul; 19(13):3481-4. PubMed ID: 19467598
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines.
Morrison R; Al-Rawi JM; Jennings IG; Thompson PE; Angove MJ
Eur J Med Chem; 2016 Mar; 110():326-39. PubMed ID: 26854431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
